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Abstract Regenerative medicine is a novel clinical
branch aiming at the cure of diseases by replacement
of damaged tissues. The crucial use of stem cells makes
this area rich of challenges, given the poorly understood
mechanisms of differentiation. One highly needed and
yet unavailable technology should allow us to monitor
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the exact (metabolic) state of stem cells differentiation
to maximize the effectiveness of their implant in vivo.
This is challenged by the fact that not all relevant
metabolites in stem cells differentiation are known
and not all metabolites can currently be continuously
monitored. To bring advancements in this direction,
we propose the enhancement and integration of two
available technologies into a general pipeline. Namely,
high-throughput biochip for gene expression screening
to pre-select the variables that are most likely to be
relevant in the identification of the stem cells’ state
and low-throughput biochip for continuous monitor-
ing of cell metabolism with highly sensitive carbon
nanotubes-based sensors. Intriguingly, additionally to
the involvement of multidisciplinary expertise (medi-
cine, molecular biology, computer science, engineer-
ing, and physics), this whole query heavily relies
on biochips: it starts in fact from the use of high-
throughput ones, which output, in turn, becomes the
base for the design of low-throughput, highly sensitive
biochips. Future research is warranted in this direction
to develop and validated the proposed device.
Keywords High-throughput biology ·
Nano-structured biochip · Stem cell differentiation ·
Metabolic pathways/markers
1 Introduction
Regenerative medicine is among the most promising
and challenging research areas related to health. Suc-
cinctly speaking, it involves the introduction in vivo
of newly/partially differentiated cells into damaged tis-
sues, that can therefore regenerate and repair whole
184 BioNanoSci. (2011) 1:183–191
organs, or in vitro generation of tissues and organs.
Pioneering work applied to cardiac surgery on ischemic
areas has generated great hopes as well as novel issues
[1]. Due to the crucial use of stem cells, challenges
range from the difficulties arising from ethical concerns
regarding embryonic stem cells—that limit the possible
systems under study—to the complexity of the process
of differentiation and the number of variables involved
in cells’ fate. Therefore, it is of the utmost importance
to offer technologies instrumental to the deciphering
of such complexity. To meet this goal, a variety of
technologies and of backgrounds are necessary to cope
with the emerging difficulties. In particular, identifying
the main processes involved in the differentiation and
monitoring in real time, the evolution of such processes
can constitute a crucial advancement in this area since
one pre-requisite for cells implant is the proper and pre-
cise knowledge of their state. Intriguingly, the quest for
such information can take the spirally formed shape of
a path where biochips play a crucial role. This path orig-
inates in the development of high-throughput biochips
allowing the identification of molecules of interest that
can serve as markers for biological processes’ further
monitoring (see Fig. 1). Before discussing the pipeline
proposed in this article to perform this integration, we
Fig. 1 Depicts an ideal path of biochips evolution, showing in-
creasing precision and decreasing throughput. The various steps
are described along this article. In particular, the first three steps,
representing standard elaboration of high-throughput biochip,
are described in Section 2, and the last three that are typical
of this approach as pre-processing for nanobiochip design, in
Section 3
briefly recollect the state of the art on the technologies
we will base our approach on.
Microarrays for gene expression are the molecular
biochips (appeared roughly 15–20 years ago [2]) that
have revolutionized biology, by leading to the gener-
ation of novel scientific branches like bioinformatics
and computational biology. Although soon-to-be over-
shaded by sequencing technologies [3, 4], their use
in differential analyses (i.e., identification of genome-
wide variations in expression among samples taken
from different patients, after different treatments, at
different time points, etc.) remains a yet cheaper and
valuable approach [5, 6]. The technical solutions used to
perform parallel hybridization are numerous but can be
grouped in two main categories, notably for the choice
of the blueprint molecules on the chip. In the first type,
they are fragments of cellular extracts and their length
goes from 20 to hundreds of base pairs (named two
channels since they perform the comparative analysis
of the molecules abundance in two cells populations);
in the second type, they are synthesized short probes
(15–25 bp) of known sequence which are able to cap-
ture specific fragments (single channel). The fragments
diluted in the sample solution are pre-processed and
coupled with a permanent marker molecule which,
once the fragment has been captured by a complemen-
tary strand on the surface of the chip, is able to generate
a localized detectable signal (hence, the well-known
microarray heatmaps). Although the reproducibility of
the results is not perfect, the MicroArray Quality Con-
trol Project, led by the US Food and Drug Administra-
tion [7] proved that findings can be shown to overlap,
provided great care is used in the definition of the
experimental protocols, and that results are compared
in terms of genes functionalities.
Conversely to the high-throughput snapshot offered
by microarrays, biosensors technology provides the di-
rect and continuous monitoring of a selected number
of metabolites. With respect to the variables to be
sensed, biosensors based on oxidases have already been
successfully proposed for the continuous monitoring of
glucose [8, 9] and lactate [10], two highly relevant mole-
cules in cell metabolism, that have also been used to
monitor cell cultures during growth and differentiation
[11]. Recent advancements have enabled the remote
monitoring of such molecules in both humans [12]
and animal models [13]. Additionally, biochips-sensing
metabolites related to P450-based metabolic pathways
have been demonstrated to be reliable [14] even in the
case of multiple substrates interacting with the same
cytochromes [15].
The combination of electrochemical detection for
metabolites sensing with carbon nanotubes has proven
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to remarkably enhance detection [16] and this approach
has recently been extended to sensing other metabo-
lites, e.g., ATP [17].
1.1 The Proposed Biochip Pipeline
In this work, the distinctive characteristic of microar-
rays, i.e., the bird’s eye, systemic view they offer, is
used as a pre-condition to identify the main molecular
variables interested in stem cells differentiation. As
depicted intuitively in Fig. 1, the derived information is
processed with bioinformatics techniques (differential
and network analysis [18, 19]) to identify the genes that
show statistically significant variations in their expres-
sion when comparing different states of the cell. This in-
formation (i.e., a set of differentially expressed genes),
is then elaborated via integration with a variety of bio-
logical databases, to generate a network of interactions
from the list of genes. Finally, the manual curation
allows to identify the pathways that are more relevant,
and from there to infer the metabolites produced, and
therefore the likely markers to be monitored: these
metabolites, in fact, can ultimately serve as sensing
variable in a low-throughput carbon nanotube-based
biochip.
The whole chain of events (molecules identification,
selection, and sensing) remains in the realm of mole-
cular biology, where, high-throughput biology serves
as a base for the generation of advanced and fo-
cused tools for the online monitoring of stem cells
differentiation. In our work, the conditions tested are
embodied by two states of rats pluripotent embryonic
stem cells (ESCs). ESCs have the capability to unlimit-
edly proliferate in vitro maintaining an undifferentiated
state. Due to their pluripotentiality, they retain the
ability to differentiate into all cell types in vivo and
can be induced to form derivatives of all three germ
layers (ectoderm, endoderm and mesoderm) in vitro.
The pluripotential properties of such cells can be as-
sessed by the expression of ESC markers such as
placental alkalin phpsphatase (AP), SSEA-1, SSEA-3,
SSEA-4, POU transcription factor octamer-4 (Oct-4),
TRA-1-60, and TRA-1-81 (1,2). When cultured in the
absence of feeder layer in no leukaemia inhibiting
factor (LIF) containing medium, rats ESC (RESCs)
are induced to form large and spherical cells aggre-
gates known as embryoid bodies (EBs) [20]. After
some days in culture, these EBs can be processed by
enzymatic and/or mechanical dissociation to obtain a
single cell suspension. If plated on appropriate coated
substrates, cells attach and upon removal of growth
factors differentiate; when ESCs start to differentiate,
the indicated pluripotency markers disappear. Using
this culture system, we can obtain both Oct-4 high-
expressing cells The cells we processed were both sin-
gle cells, thus true ESCs, and Oct-4 low-expressing
cells. Therefore, we can speculate to have a very early
differentiation stage from our Oct-4-positive cells.
The elucidation of the stem cells metabolism during
differentiation and especially at the early phases of such
a transition could lead to a better understanding of
embryonic stem cells behavior and to the identification
of crucial markers for monitoring their behavior. Our
aim was to mark a transcriptional difference between
two close developmental states distinguishable for the
expression of Oct-4. It is generally accepted that Oct-4
is one of the 3 crucial molecules in the core regulatory
network maintaining the ESC pluripotency [21]. Thus,
this cell system is a preferential candidate to study
possible metabolic markers (and biosensors targeting
molecules of metabolic interest) able to monitor stami-
nality and/or differentiation.
On the sensor side, the pathways mapped by the
differential and networking analysis can be screened
(using number of databases [18, 22]) in search of en-
zymes that play a significant role in metabolic regula-
tion. For example, some oxidases are involved, with a
number of common molecules (such as glucose, lactate,
glutamate, etc.), in reactions that have a key role in cell
metabolism. Similarly, enzymes of the superfamily of
the cytochromes P450 are involved in the metabolism
of both endogenous and exogenous metabolism in all
eukaryotic organism [14]. Such classes of enzymes link
the genes identified to be relevant in the differentiation
process, with the molecules that can be sensed to mon-
itor such differentiation, and therefore they are crucial
toward the development of low-throughput biochip for
continuous cell monitoring.
2 Materials and Methods
2.1 Cell Culture and mRNA Collection
RESCs were cultured as clusters for two passages on
mouse embryonic fibroblasts (MEF) and one passage
without MEF from thawing. Afterwards, single cell
suspensions were derived and cultured for further two
passages in SCML medium. SCML medium was pre-
pared as described by Turksen [23] and it was supple-
mented with 4 ng/ml bFGF and 2 × 103 U/ml LIF. At
this stage, Oct-4 high-expressing cells were collected
or further cultured for 10 days without bFGF and LIF
to yield Oct-4 low-expressing cells. Embryonic stem
cells were cultured under two conditions: the Oct-4-
positive and Oct-4-negative state. For each condition,
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three replicates where obtained in two different batches
of experiments (these were processed in three different
cell batches; two were screened together and one
subsequently, with microarray for gene expression).
RNA were extracted from single cells cultured with or
without mitogens with miRNAeasy mini kit (Qiagen,
Milan, Italy) according to the recommendation of the
manufacturer.
2.2 Microarrays for Gene Expression
Microarrays experiments (one channel technology)
were performed at Genopode (http://www.unil.ch/
acces/page36639_fr.html), using Affymetrix Rat Gene
1.0 ST arrays, with 27,342 transcripts, according to the
manufacturer’s instructions.
2.3 Differential Analysis
The raw microarray data were pre-processed using
affymetrix power tools with RMA normalization. The
three replicates were obtained from two batches, there-
fore the analysis was performed within and between
batches to assess the entity of the bias due to the
batch effect. For the two microarray samples from
experiment of round 1, fold change was used to se-
lect differentially expressed probes, cut-off set to two
[24]. For the four microarray samples from experiment
of round 2 and the combined six microarray samples
(all data analysis) since there were only few replicates
(2–5/group), the moderated t-statistics method [25],
making use of the limma R-package was adopted.
Probes with p values of ≤0.001 were selected to be sta-
tistically significant. As an additional filtering criteria,
we removed all the differentially expressed probes with
average expression <4.5, as well as the ones showing no
mRNA annotation.
3 Results and Discussion
The results of the differential analysis lead to the iden-
tification of the genes that have undergone important
changes during the experiment, i.e., before and after
early differentiation (Oct-4 high-/low-expressing state).
The results in this form consist of an annotated list
of meaningful genes. However, in order to achieve in-
formation relevant for the identification of the metabo-
lites that may be involved in this early step of the
differentiation, another type of output, able to capture
the complexity of the genes interactions, is necessary.
In particular, the representation of genes interconnec-
tions, using a graph, appears to be suitable for this prob-
lem and is commonly used in computational biology. A
graph is a set G = {N, E}, where G represents the set
of nodes (i.e., annotated genes) and E the set of edges
(that is the connections occurring among these genes).
Computational biology is concerned with multiple way
of reconstructing such graphs, and the most appro-
priate for the current experimental design relies on
literature databases where number of connections are
listed, based on a variety of published experiments. In
particular, STRING [18] offers the needed flexibility to
draw this network. STRING is a database of known and
predicted protein interactions including direct (physi-
cal) and indirect (functional) associations derived from
four sources: genomic context, high-throughput exper-
iments, coexpression and previous knowledge (litera-
ture). The four sources can be further extended into
eight types of evidences for associations while in the
resulting map, different line colors represent the types
of evidence. The confidence score is an indicator of the
robustness of the connection and is set to medium by
default.
In particular, Oct-4 downregulation following mi-
togens withdrawal results in the differential expres-
sion of 1˜20 relevant genes (listed in Supplementary
Information) which resulting network, processed with
STRING, is shown in Fig. 2. Two very interesting clus-
ters of genes around insulin-like growth factor (IGF)-1
and TGF-b and related receptors are identified. IGF-1
which we found to be downregulated after Oct-4 down-
regulation and reduction of pluripotency is a hormone
similar in molecular structure to insulin. In humans,
it plays an important role in childhood growth and
stimulates anabolic processes also in adults. Both the
insulin and IGF-1 receptors (IGF-1R) are expressed
in the trophectoderm cells and trophoblast tissue [26].
IGF plays a critical role in promotion of survival and
proliferation in a diversity of cell types, including both
embryonic and adult stem cells. It was also recently
shown that self renewal of human embryonic stem
cells requires insulin-like IGF-1R [27] and that IGF
could act as a co-stimulatory factor for reprogramming
somatic cells into induced pluripotent stem cells [28].
These evidences match with our observation that IGF-
1 downregulation occurs during Oct-4 downregulation
and consequent decline of RESC pluripotency. On the
basis of the crucial and complex role of IGF-1 in the
regulation of cell differentiation, survival and prolif-
eration [29] we can speculate that our cellular system
undergoes profound modifications related to pluripo-
tency and differentiation when Oct4 is downregulated
and thus represents an appropriate model to identify
potential molecular targets for stem cell monitoring.
Since the metabolic responses of differentiating stem
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Fig. 2 STRING Network. Color code for edges interpretation:
neighborhood (green), gene fusion (red), cooccurrence (blue),
coexpression (dark), experiments (pink), databases (sky blue),
textming (kelly), and homology (purple). Only connected genes
are depicted, therefore the differentially expressed genes that
appeared as isolated nodes where not added in this figure
cells have been poorly investigated despite their po-
tential relevance for the stem cell behavior [30, 31],
we focused on the differentially expressed genes which
are ontologically related to cellular metabolism and/or
encode for enzymes and transporters for extracellular
metabolic substrates. In this context, on the basis of
its in vivo role in metabolism regulation, the unex-
plored possibility that IGF-1 differential expression
could results in changes in the metabolic state of em-
bryonic stem cells should be investigated, the full list
can be found in Online Resource 1. Furthermore, we
retrieved an upregulation of Stc1, Per1, Per3, and Insig1
after mitogen withdrawal, for which a clear role
in the regulation of the cell metabolism was indi-
cated [32–35]. More generally, we identified subsets
of genes in the extracellular region or space whose
regulation in the two experimental conditions that
we investigated could result in changes of detectable
extracellular molecules (i.e., enzymes, and trans-
porters for metabolites, proteins, polysaccharides as
well as key detectable molecules such as hormones).
In this context, we found a significant upregula-
tion of Adm(adrenomedullin), Acpp (acid phospha-
tase, prostate), hyaluronoglucosaminidase 1 (Hyal-1),
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transcobalamin II (Tcn2), stanniocalcin 1 (Stc1),
prostaglandin I2 (prostacyclin) synthase (Ptgis), alde-
hyde dehydrogenase 6 family member 9 (Aldh6a1),
and mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-
acetylglucosaminyltransferase (Mgat4a), see Table 1.
This analysis permits the identification of portions
of pathways involved in the differentiation and also to
highlight in particular genes that appear to be more
relevant to our quest. However, an additional step is
needed to connect these pathways to the identification
of the metabolites that are secreted by the cell and can
be sensed as a marker of the cell’s state.
Toward this aim, given the clearer signal shown by
the variation in expression of the genes in Table 1, we
investigated deeper their relation to potential sensing
metabolites, in particular searching for connections in
the pathways related to the cytochrome P450 super-
family, which will serve as the base of the nanocarbon
biosensor. In rat, the enzymes belonging to the P450 su-
perfamily catalyze several metabolic reactions, among
which steroid hormone biosynthesis, drug metabolism
and linoleic acid metabolism. Since the eight genes
identified above are also enzymes, involved in several
metabolic reactions, we used the KEGG pathway [22]
database to build the connections among them. First,
we searched the relationships among the eight genes,
by identifying the individual metabolic pathways each
gene is involved in. As it is shown in Fig. 3 Acpp
is involved in Riboflavin metabolism, Hyal1 in gly-
cosaminoglycan degradation, Aldh6a1 in several path-
ways such as valine, leucine and isoleucine degrada-
tion, Inositol phosphate metabolism and Propanoate
metabolism, Mgat4a in N-glycan biosynthesis, Ptgis in
Arachidonic acid metabolism and Tcn2 in Vitamin di-
gestion and absorption. The last two genes, Adm and
Stc1, do not participate in any metabolic pathways.
Table 1 Genes symbols, fold change (logarithm), and gene de-
scription of the eight genes found to be significantly upregulated
in the early differentiation
Gene symbol logFC Gene description
Acpp 1.54 Acid phosphatase, prostate
Hyal-1 1.46 Hyaluronoglucosaminidase 1
Aldh6a1 1.36 Aldehyde dehydrogenase 6 family,
member A1
Mgat4a 1.06 Mannosyl (α-1,3-)-glycoprotein
β-1,4-N-acetylglucosaminyltransferase,
isozyme A
Ptgis 1.78 Prostaglandin I2 (prostacyclin) synthase
Tcn2 1.41 Transcobalamin 2
Adm 2.23 Adrenomedullin
Stc1 2.22 Stanniocalcin 1
We then used the whole metabolic pathways of rat
to find the connections of the six genes involved in
different metabolic pathways, four out of six genes
can be linked through serial metabolic reactions. Fi-
nally, we added the P450 enzymes—due to their pos-
sible use in sensors base—to this map through the
shared metabolites. They appear to be related to
the highlighted molecules via the caffeine, arachi-
donic acid, and linoleic acid metabolisms. For ex-
amples, Cyp1a2/Cyp2a1/Cyp2a3/Cyp2a2 can all cat-
alyze 1,7-dimethyluric acid to 1,7-dimethylxanthine,
and these enzymes can be linked to the original
map through a serial metabolic pathways according
to the shared metabolite 5-phospho-alpha-d-ribose-1-
diphoshphate, a majority of P450 enzymes such as
Cyp2c22/Cyp2c13/Cyp2c6 catalyze the metabolic reac-
tion from Linoleate to 12(13)-EpOME and other reac-
tions. Since these proteins all belong to the p450 family,
they may share some similar functions, and therefore
can catalyze the same reactions. In particular, these
enzymes can be connected to the map by the common
metabolite D-Glyceraldehyde 3-phosphate and beta-d-
fructose 1,6-bisphosphate. Additionally, by direct in-
spection of Fig. 3, we can identify very interesting con-
nections between the identified genes and molecules
such as Lactose and Galactose, that can be easily sensed
with assessed nanotechnology. With respect to mole-
cules that act as substrates for the P450 proteins family
[36] (see Table 2 for a partial list), we can observe
that the ones identified in this study (highlighted in
bold) have already been sensed with this approach, and
namely: caffeine [37], arachidonic acid [38], arachido-
nate [39], and linoleic acid [40].
Therefore, this research has highlighted a relevant
set of metabolites that can be used to develop a multi-
panel biochip for monitoring cultured stem cells by
following glucose, lactate, caffeine, arachidonic acid,
arachidonate, and linoleic acid time trends as molecular
markers of the cell metabolism. One actual direction
emerging from this analysis is therefore to develop a
biochip based on glucose and lactate oxidases as well as
on the P450 isoforms shown in Table 2.
Additionally, urate oxidase (Uox) through the
purine metabolism pathway and tyrosinase through
the riboflavin metabolism pathway (highlighted in
purple in the map, Fig. 3) can also bring relevant
information. In fact, Uox catalyzes the transforma-
tion of uric acid in 5-hydroxyisourate, while purine
is synthesized by catalytic reactions that involve
several different metabolites, including 5-phospho-d-
ribosyl 1-pyrophosphate. The last reacts with gluta-
mine to form 5′-phosphoribosylamine, glutamine, and
pyrophosphate. Therefore, uric acid and glutamine are
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Fig. 3 The connected pathways related to the genes identified
directly in the differential analysis (in red), to the p450 family (in
blue) and to urate oxidase (Uox), via the purine metabolism path-
way and to tyrosinase (Tyr) through the riboflavin metabolism
pathway (in purple). High-resolution file of this figure is available
as Online Resource 2
Table 2 Lists of metabolites
and the P450 superfamily
isoforms for which they are
substrates
Substrates set in italics are the
ones highlighted as relevant
in this analysis
Substrate p450 Isoforms
Testosterone 3A4, 5, 7, and 43
Arachidonic acid 4A11, 4A22, 4B1, 4F2,3, 8 4F11, 4F12 4V2, 4X1, and 4Z1
Thromboxane A2 synthase 5A1
Bile acid 7A1 and 7B1
Prostacyclin synthase 8A1
Vitamin D 24A1
Retinoic acid hydroxylase 26A1, 26B1, and 26C1
Linoleate 2E1, 1A2, 2A2, 9, 18, and 23
Dymetil-xantine 1A1 and 2,3
Cafeine 1A2
Arachidonate 2B1, 3, 12, and 21; 4A1, 2, 3, and 10; 2C6, 7, 11, 12, 13, and 22;
(anion of arachidonic acid) 2J3, 4, and 16
cholesterol 51A1
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additional possible metabolic targets to be included
in future devices for continuous monitoring of cell
cultures, based on biosensors for uric acid [41] and
glutamine and glutamate [42].
4 Conclusions
Our gene expression analysis showed that the tight
and multidisciplinary interaction among molecular bi-
ologists, bionformaticians, and engineers, following a
multi-step pipeline based on a variety of tools, can
generate original findings that become the input for
the generation of novel information first, and of novel
technology then, in a continuous and virtuous spiral of
improvement.
The example we have shown outputs a set of metabo-
lites that can be considered to develop a completely
new low-throughput biochip for continuous monitoring
(with an extremely fine time scale) stem cell cultures
at the single metabolite level. Therefore, the synergy
between the high-throughput techniques with the low-
throughput one, became the next frontier for previously
un-imaginable investigations. Despite currently being
limited to a single biological system, the approach we
are proposing can be extended to a number of systems,
and it represents a proof of principle of the feasibility of
such approach. Nevertheless, we understand that num-
ber of obstacles are still to be overcome in moving from
the identification of the sensing and sensed variables
to the actual chip implementation. However, we expect
such type of work to become more and more popular,
given the growing number of high-throughput screens
that are being made available at lower costs [43] and the
consequent more precise approaches and tools that can
be developed [44] to get more insight into the molecular
complexity shown by these screens.
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